Otc - Active Ingredient
Lidocaine HCl 4%
Warrior Pain Relief Roll-on Gel
FDA Label NDC 72839-108
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Derma Care Research Labs, Llc for the product Warrior Pain Relief Roll-on (NDC 72839-108). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding otc - active ingredient, otc - purpose, dosage & administration, warnings, otc - keep out of reach of children, indications & usage, inactive ingredient, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Otc - Purpose
Topical Analgesic
Dosage & Administration
For the temporary relief of pain and itching.
Warnings
For external use only.
When using this product use only as directed, avoid contact with eyes, and do not use in large quantities, particularly over raw surfaces or blistered areas. Stop use and ask a doctor if the condition worsens, symptoms persist for more than 7 days or clear up and occur again within a few days.
Otc - Keep Out Of Reach Of Children
In case of accidental ingestion, seek professional assistance or contact a Poison Control Center immediately.
Indications & Usage
Adults and children 2 years and older: apply to the affected area, not more than 3 to 4 times daily. Children under 2 years of age: ask a doctor.
Inactive Ingredient
Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Aloe Barbadensis Leaf Extract, Aminomethyl Propanol, C30-45 Alkyl Cetearyl Dimethicone Crosspolymer, Caprylyl Methicone, Cetearyl Alcohol, Ceteth-20 Phosphate, Dicetyl Phosphate, Dimethicone, Disodium EDTA, Ethylhexylglycerin, Glyceryl Stearate, Methylparaben, SD Alcohol 40, Steareth-21, Water.
* Please review the disclaimer below.
